ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,805.97
      1.58%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      01/18/20194:36PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ACRSAclaris Therapeutics Inc
      01/18/20192:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      01/02/20195:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      01/02/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20187:36AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20187:35AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20187:34AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20187:33AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20187:31AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/20/20184:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      12/20/201810:28AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRSAclaris Therapeutics Inc
      12/17/20184:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      12/17/20184:01PMGlobeNewswire Inc.Aclaris Therapeutics Provides Update on Oral and Topical JAK 1/3 Inhibitor Clinical TrialsNASDAQ:ACRSAclaris Therapeutics Inc
      12/10/20189:04AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      12/03/20184:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      12/03/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics Closes Acquisition of RHOFADE® (oxymetazoline hydrochloride) cream, 1% from AllerganNASDAQ:ACRSAclaris Therapeutics Inc
      11/28/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      11/06/20185:27PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      11/06/20184:37PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/06/20184:01PMGlobeNewswire Inc.Aclaris Therapeutics Reports Third Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments...NASDAQ:ACRSAclaris Therapeutics Inc
      11/02/20184:01PMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      11/01/20184:03PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      10/31/20184:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      10/29/20184:01PMGlobeNewswire Inc.Aclaris Therapeutics to Announce Third Quarter 2018 Financial Results on November 6, 2018NASDAQ:ACRSAclaris Therapeutics Inc
      10/24/201810:19AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACRSAclaris Therapeutics Inc
      10/24/201810:15AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      10/23/20187:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      10/22/20184:01PMGlobeNewswire Inc.Aclaris Announces Closing of Public Offering of Common StockNASDAQ:ACRSAclaris Therapeutics Inc
      10/18/20184:09PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRSAclaris Therapeutics Inc
      10/18/20184:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS